Your institution may have access to this item. Find your institution then sign in to continue.
Title
A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.
Authors
Gan, Hui K; Mitchell, Paul L; Galettis, Peter; Davis, Ian D; Cebon, Jonathan; de Souza, Paul; Links, Matthew
Abstract
This dose escalation study aimed to determine the recommended doses, toxicity and pharmacokinetics of oxaliplatin and gemcitabine given on days 1 and 8 every 21 days. This schedule may maximize dose intensity of both drugs with acceptable or reduced toxicity.
Publication
Cancer chemotherapy and pharmacology, 2006, Vol 58, Issue 2, p157